Bambuser partners with Meta on Live Video Ads for brand-owned live shopping
Bitget2026/10/08 12:04Bambuser entered a partnership with Meta as a Live Video Ads partner, integrating paid distribution with brand-owned live shopping streams. Live video ads use the livestream as the ad creative, sending viewers to a brand site running Bambuser’s shoppable player or Meta messaging. Early access applications open later in Q4 2026; general availability targeted for Q1 2027 for eligible customers in supported markets. Meta data cited: livestreams backed by at least $100 in ad spend reached 24 times more viewers than organic broadcasts. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bambuser AB published the original content used to generate this news brief on October 08, 2026, and is solely responsible for the information contained therein.
- Bambuser entered a partnership with Meta as a Live Video Ads partner, integrating paid distribution with brand-owned live shopping streams.
- Live video ads use the livestream as the ad creative, sending viewers to a brand site running Bambuser’s shoppable player or Meta messaging.
- Early access applications open later in Q4 2026; general availability targeted for Q1 2027 for eligible customers in supported markets.
- Meta data cited: livestreams backed by at least $100 in ad spend reached 24 times more viewers than organic broadcasts.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
